Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Uncemented Total Hip Arthroplasty
NCT01630941Phase 2Completed
- Start
- Aug 2012
- Primary completion
- Jan 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in osteoarthritis (OA). Started Aug 2012; status: completed.
02
Drugs
denosumab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01630941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01630941.